Last reviewed · How we verify

NCT03794063

Analysis of Caesarean Section Rate According to the Robson Classification System

Status unknown Last updated 18 July 2019
What this trial tests

trial testing Robson 10 group classification system in Caesarean Section Rate in 3,000 participants. Status unknown.

Timeline
10 March 2019
Primary endpoint
1 August 2019
1 August 2019

Quick facts

Lead sponsorEgyptian Society of Royal College of Obstetricians and Gynaecologists
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment3,000
Start date10 March 2019
Primary completion1 August 2019
Estimated completion1 August 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Egyptian Society of Royal College of Obstetricians and Gynaecologists

Who can join

Eligibility, female only, with Caesarean Section Rate. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective cross- sectional study will be conducted to implement the Robson Classification to assess, analyze and compare Caesarean section rate of the participating hospital over the period of three months. The Robson implementation manual will be used as a tool guide for the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03794063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing